Management of cytomegalovirus infection in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations
| Autor: | Jordi Carratalà, Elisa Cordero, Pilar Martín-Dávila, Nicolás Manito, E. Frauca, Daniela Paredes Hernandez, J. Torre-Cisneros, Juan José Castón, Sara Cantisán, A. Rodriguez-Bernot, David Navarro, E. Vidal, Oscar Len, José Rumbao, Ignacio Herrero, Miguel Montejo, José M. Vaquero, Patricia Muñoz, Carlos Cervera, Joan Gavaldà, A. Moreno, R. San Juan, María Carmen Fariñas, J. Fortún, Víctor Monforte, Alejandro Alonso, Francisco López-Medrano, Mario Fernández-Ruiz, Pilar Pérez-Romero, Luis Almenar, M. A. Marcos, José María Aguado |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
medicine.medical_specialty
Congenital cytomegalovirus infection MEDLINE Drug resistance 030230 surgery Antiviral Agents Organ transplantation 03 medical and health sciences 0302 clinical medicine Monitoring Immunologic Medicine Humans Major complication Intensive care medicine Transplantation business.industry Organ Transplantation medicine.disease Transplant Recipients Cytomegalovirus infection Clinical microbiology Immunology Cytomegalovirus Infections Practice Guidelines as Topic 030211 gastroenterology & hepatology business Solid organ transplantation |
| Zdroj: | Transplantation reviews (Orlando, Fla.). 30(3) |
| ISSN: | 1557-9816 |
| Popis: | Cytomegalovirus (CMV) infection remains a major complication of solid organ transplantation. Because of management of CMV is variable among transplant centers, in 2011 the Spanish Transplantation Infection Study Group (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) developed consensus guidelines for the prevention and treatment of CMV infection in solid organ transplant recipients. Since then, new publications have clarified or questioned the aspects covered in the previous document. For that reason, a panel of experts revised the evidence on CMV management, including immunological monitoring, diagnostics, prevention, vaccines, indirect effects, treatment, drug resistance, immunotherapy, investigational drugs, and pediatric issues. This document summarizes the recommendations. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect